Mots-clés
> MYOBASE > SOCIETE > démographie > épidémiologie > morbidité > prévalence
prévalence
Commentaire :
Nombre total de cas d'une maladie dans une population donnée pendant un temps déterminé, sans distinction entre cas anciens et nouveaux. (d'après le MeSH ; 10/08/2005)
|
Documents disponibles dans cette catégorie (689)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Etendre la recherche sur niveau(x) vers le bas
Article
Akesson LS ; Savarirayan R | 2020Clinical characteristics. Fibrodysplasia ossificans progressiva (FOP) is characterized by congenital bilateral hallux valgus malformations and early-onset heterotopic ossification, which may be spontaneous or precipitated by trauma including [...]Article
Leurs A ; Dubucquoi S ; Machuron F ; Balden M ; Renaud F ; Rogeau S ; Lopez B ; Lambert M ; Morell-Dubois S ; Maillard H ; Behal H ; Hachulla E ; Launay D ; Sobanski V | France | 2020Article
Article
Article
Article
Article
Labrador E ; Weinstein DA | 27/11/2019Initial Posting: April 23, 2009; Last Update: November 27, 2019. Clinical characteristics. Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzy[...]Article
Chong-Nguyen C ; Stalens C ; Goursot Y ; Bougouin W ; Stojkovic T ; Behin A ; Mochel F ; Berber N ; Eymard B ; Duboc D ; Laforet P ; Wahbi K | United States | 11/2019Article
Higgs C, Auteur ; Hilbert JE ; Wood L ; Martens WB ; Marini-Bettolo C ; Nikolenko N ; Alsaggaf R ; Lochmuller H ; Moxley RT ; Greene MH ; Wang Y ; Gadalla SM | Switzerland | 10/2019Article
Desai R, Auteur ; Abbas SA ; Fong HK ; Lodhi MU ; Doshi R ; Savani S ; Gangani K ; Sachdeva R ; Kumar G | Netherlands | 10/2019Publication AFM
Myoinfo, Auteur ; Duguet C, Validateur ; Dupitier E, Validateur ; Eymard N, Validateur ; Lagrue E, Validateur ; Reveillere C, Validateur ; Urtizberea JA | AFM-TELETHON | Savoir & Comprendre | 10/2019L’amyotrophie spinale proximale liée au gène SMN1 est une maladie rare qui se manifeste par une faiblesse musculaire d’importance variable exceptionnellement présente dès la naissance ou apparaissant par la suite, dans l’enfance, à l’adolescence[...]Article
Kimonis V | 12/09/2019Initial Posting: May 25, 2007; Last Update: September 12, 2019. Clinical characteristics. Inclusion body myopathy associated with Paget disease of bone (PDB) and/or frontotemporal dementia (IBMPFD) is characterized by adult-onset proximal [...]Article
Article
Runte M ; Spiesshoefer J ; Heidbreder A ; Dreher M ; Young P ; Brix T ; Boentert M | Germany | 09/2019Article
Penttila S ; Vihola A ; Palmio J ; Udd B | 22/08/2019Initial Posting: November 29, 2012; Last Update: August 22, 2019. Clinical characteristics. The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal m[...]Article
Bonne G ; Leturcq F ; Ben Yaou R | 15/08/2019Initial Posting: September 29, 2004; Last Update: August 15, 2019. Clinical characteristics. Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progr[...]Article
Magoulas PL ; El-Hattab AW | 01/08/2019Initial Posting: January 3, 2013; Last Update: August 1, 2019. Clinical characteristics. The clinical manifestations of glycogen storage disease type IV (GSD IV) discussed in this entry span a continuum of different subtypes with variable ag[...]Article
Article
Saito K | 03/07/2019Initial Posting: January 26, 2006; Last Update: July 3, 2019. Clinical characteristics. Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that[...]Article
Initial Posting: June 20, 2019. Clinical characteristics. STAC3 disorder is characterized by congenital myopathy, musculoskeletal involvement of the trunk and extremities, feeding difficulties, and delayed motor milestones. Most affected ind[...]Article
Initial Posting: August 5, 2008; Last Update: June 6, 2019. The purpose of this overview is to increase clinician awareness of the genetic basis of hypertrophic cardiomyopathy (HCM) and the benefits of early diagnosis and management to indivi[...]Article
van der Velden BG, Auteur ; Okkersen K ; Kessels RP ; Groenewoud J ; van Engelen B ; Knoop H ; Raaphorst J | 01/05/2019Article
Wieser T | 03/01/2019Initial Posting: August 27, 2004; Last Revision: January 3, 2019. Clinical characteristics. Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal n[...]Article
El-Hattab AW ; Almannai M ; Scaglia F | 29/11/2018Initial Posting: February 27, 2001; Last Update: November 29, 2018. Clinical characteristics. MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is a multisystem disorder with protean manifestations. The vast [...]